Tag: Christian Stief

ProtecT trial shows classical risk categories don’t help

EAU17: ProtecT trial shows classical risk categories don’t help

The classical risk categories used to stage prostate cancer disease do not aid clinical decision-making as much as PSA, biopsy, Gleason score, biopsy results and other measurements, according to an expert who commented during the Late-Breaking news segment of...